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Edited by Gianni CesareniAbstract Jun activation domain-binding protein 1 (Jab1) is
a coactivator of activating protein-1 (AP-1) and is the ﬁfth com-
ponent of the COP9 signalosome complex. It interacts with a
variety of proteins and plays important roles in diverse signaling
pathways and cellular function including oncogenesis. We show
here that Jab1 interacts in vivo with nuclear receptor binding
protein (NRBP), an evolutionarily conserved adapter protein
with a kinase-like domain. We further show that NRBP inhibits
Jab1-induced phosphorylation of c-Jun and AP-1 activation.
Finally, overexpression of NRBP in mammalian cells speciﬁcally
inhibits AP-1 activation by various stimuli. Taken together, our
data suggest that NRBP may be an important negative regulator
of Jab1-mediated functions such as gene transcription and tumor
progression.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The COP9 signalosome (CSN) was originally identiﬁed in
Arabidopsis as a negative regulator of photomorphogenesis
[1]. In mammalian cells, the complex is composed of eight sub-
units and is involved in protein phosphorylation and degrada-
tion [2–5]. Each subunit of the CSN has been identiﬁed as the
binding partner of many other proteins and thus has speciﬁc
functions [6]. The precise biochemical functions of the CSN
complex are still under intensive investigation. However, each
subunit has been independently characterized [7–9]. Jun activa-
tion domain-binding protein 1 (Jab1), initially identiﬁed as a
coactivator of AP-1 [10], is the ﬁfth component (CSN5) of
the CSN complex [11,12]. It was ﬁrst identiﬁed through its
interaction with the activation domain of c-Jun [10]. It was
found to stabilize transcription factor complexes containing
c-Jun or JunD at their AP-1 binding sites, leading to an in-Abbreviations: NRBP, nuclear receptor binding protein; Jab1, Jun
activation domain-binding protein 1; AP-1, activating protein-1
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Jab1 has also been shown to interact with a variety of proteins
and control their functions, including regulation of gene tran-
scription and cell cycle via phosphorylation, and degradation
of target proteins [13]. For instance, interaction of Jab1 with
the tumor suppressor p53 induces CSN-mediated phosphory-
lation and subsequent degradation of p53 [2]. Jab1 is also
known to interact with the cyclin-dependent kinase inhibitor
p27kip1 and decrease the stability of p27kip1, a process
strongly associated with tumor progression [14]. A number
of cellular factors and proteins including Vitamin D3 up-regu-
lated protein 1 (VDUP1), migration inhibitory factor (MIF),
and integrin LFA-1 have been shown to interact with Jab1
and modulate the Jab1-mediated functions such as AP-1 activ-
ity and cell proliferation [15–17].
NRBP is an ubiquitously expressed adapter protein contain-
ing a potential Src homology 2 (SH2) domain binding region, a
kinase-like domain, and a myeloid leukemia factor 1 (Mlf1)
binding region [18,19]. It represents a family of evolutionarily
conserved proteins with homologs in C. elegans, D. melanogas-
ter, mouse and human. Intriguingly, the kinase-like domain of
NRBP, which contains signiﬁcant homology with other kinase
domains, lacks the conserved ATP-binding motif. To date, lit-
tle is known about the function of NRBP except its interaction
with a few cellular proteins. For example, the small GTPase
Rac3 has been shown to form a complex with NRBP. How-
ever, overexpression of NRBP in mammalian cells failed to
activate downstream targets of Rac3 including the JNK and
the p38 pathway or associate with actin cytoskeletal rearrange-
ments. Nonetheless, expression of NRBP led to signiﬁcant
redistribution of Golgi-associated marker p58 to the peripheral
ER compartment, suggesting it may be involved in subcellular
traﬃcking [20]. The highly conserved murine homolog of
NRBP, MADM, has been shown to bind to Mlf1 oncoprotein,
and mediate phosphorylation of the 14-3-3 binding site of Mlf1
[19]. Since MADM does not contain an ATP-binding motif in
its putative kinase domain, it is hypothesized that the murine
homolog of NRBP associates with an unknown serine-threo-
nine kinase that phosphorylates Mlf1 and modulates its activ-
ity. In addition, given the presence of a nuclear localization
and a nuclear export sequences in MADM, it may shuttle be-
tween the nuclear and cytoplasmic compartments, potentially
regulating the subcellular localization and activity of Mlf1.
In this study, we employed a yeast-two hybrid screening and
identiﬁed that a key gene activation and growth regulator Jab1blished by Elsevier B.V. All rights reserved.
6016 H. Wang et al. / FEBS Letters 580 (2006) 6015–6021interacts with NRBP in vivo. Moreover, overexpression of
NRBP in mammalian cells signiﬁcantly impaired Jab1-medi-
ated AP-1 activation. We further provided evidence that
NRBP negatively regulates stimuli-induced activation of AP-
1, but not NFjB. Our data strongly suggest that NRBP may
be an important modulator in Jab1-mediated cellular function.2. Materials and methods
2.1. Yeast two-hybrid screen
A yeast two-hybrid screen was performed using the Matchmaker
GAL4 Two-Hybrid System 3 (Clontech). Full-length human NRBP
cDNA was subcloned into pGBKT7 vector and the resulting bait plas-
mid was used to screen a pACT2 HeLa cell cDNA library (Clontech)
following the manufacturer’s protocol. A total of 7.5 · 105 colonies
were screened and those that grew on selection plates were streaked
on fresh plates. To eliminate false-positives, colonies were assayed
for b-galactosidase activity using X-gal as the substrate.2.2. Cell line and transfection
Human embryonic kidney (HEK) 293T cells were purchased from
ATCC (ATCC: CRL-11268) and were maintained in Dulbecco’s mod-
iﬁed Eagle’s medium (DMEM, Hyclone, USA) containing 10% FBS
(GIBCO). Cells were transfected with indicated plasmids using the
Lipofectamine 2000 reagent (Invitrogen) according to manufac-
turer’s instructions. Simian virus 40 T antigen-transfected human leu-
kemic Jurkat T (Jurkat-TAg) cells (ATCC TIB-152) were grown in
RPMI 1640 medium (PAA, USA) supplemented with 10% FBS (GIB-
CO). Cells were transfected with indicated plasmids using the Superfect
transfection reagent (QIAGEN).2.3. Coimmunoprecipitation and Western blots
A glutathione S-transferase fusion protein consisting of the ﬁrst 100
amino acids of NRBP was expressed in Escherichia coli using pGEX-
6P-1 as previously described [19]. The fusion protein was puriﬁed, and
antisera were raised in rabbits and subsequently puriﬁed. The cDNAs
encoding wildtype and truncated human NRBP were subcloned into
the pEF1a-promoter-driven expression vector in-frame with either an
N-terminal Flag epitope followed by an IRES GFP. The full-length
human Jab1 was subcloned into a pHA expression vector (Clontech)
with an N-terminal HA epitope. HEK 293T cells were transfected with
indicated plasmids. After 24 h, cells were harvested and lysed in 200 ll
NP-40 lysis buﬀer (1% NP40, 150 mM NaCl, 10 mM Tris–HCl (pH
7.5), 5 mM EDTA and protease inhibitors, as previously described)
[21]. Twenty microliter of lysates were used for western blot analysis
to compare protein expression levels. For coimmunoprecipitation,
100 ll cell lysates were incubated with indicated antibodies at 4 C
for 1 h and with protein G-Sepharose beads (Sigma) for 2 h at 4 C.
After the beads were washed with lysis buﬀer, the bound proteins were
eluted by boiling in SDS sample buﬀer, separated by SDS–PAGE, and
electrophoretically transferred to PVDF membranes (Millipore, Bed-
ford, MA). The membranes were incubated with indicated primary
antibodies followed by secondary anti-mouse IgG horseradish peroxi-
dase (HRP) (Santa Cruz Biotechnology) and assayed by enhanced
chemiluminescence (SuperSignal Western Blotting Kit, PIERCE).
Coimmunoprecipitation of endogenous Jab1 with endogenous NRBP
was performed with lysates of HEK 293T cells. Cell lysates were incu-
bated with either the rabbit polyclonal anti-NRBP serum or the con-
trol preimmune serum at 4 C for 2 h, followed by incubating with
protein G-Sepharose beads (Sigma) for additional 2 h at 4 C. Bound
proteins were visualized by sequential Western blotting with the anti-
Jab1 antibody and anti-NRBP antiserum.2.4. Reporter gene assays
Approximately 1 · 105 293T cells were plated into each well of a 24-
well plate 24 h before transfection. The indicated cDNAs with pAP1-
luc reporter plasmid (Clontech) were cotransfected into cells. Empty
vector was added to each transfection to keep the total amount of
DNA constant. pRL-TK was used to standardize the eﬃciency of
transfection. Cells were harvested 24 h after transfection, lysed in thereporter lysis buﬀer (Promega) and assayed using the Dual-Luciferase
Reporter Assay System (Promega). Luciferase activity was measured
with a luminometer (Dynex Technology). For cell treatment, 293T cells
were stimulated at 37 C in the growth medium containing 40 ng/ml of
PMA. After 8–12 h, cells were lysed and assayed as above. For Jurkat
TAg cells, plasmids were transfected using the Superfect transfection
reagent (QIAGEN). Cells were cultured for 40 h after transfection
and aliquoted into a 96-well plate. They were stimulated at 37 C in
the growth medium containing 1 lg/ml anti-TCR hybrioma superna-
tant. After 8 h stimulation, cells were lysed and assayed as described
above.2.5. Antibodies
Mouse monoclonal anti-phospho-Jun (Ser-63) antibody, anti-Jab1
antibody and Goat anti-mouse IgG secondary antibody-conjugated
with HRP were from Santa Cruz Biotechnology. Mouse monoclonal
anti-Flag M2 (DYKDDDDK) antibody and anti-HA (hemagglutinin:
YPYDVPDYA) antibody (12CA5) were obtained from Roche Diag-
nostics (Indianapolis, IN, USA). Polyclonal rabbit antiserum against
human NRBP was generated against bacterially produced recombi-
nant protein (Shanghai Genomics).3. Results
3.1. NRBP interacts with Jab1 in yeast and in mammalian cells
To identify proteins that interact with NRBP, full-length
human NRBP was used as the bait in a yeast two-hybrid screen
against a Hela cDNA library. The initial screening identiﬁed
four independent colonies that grew in the absence of Trp,
Leu, and His. All of these colonies were further conﬁrmed to
possess b-galactosidase activity, and the subsequent sequence
analyses identiﬁed two of the clones containing cDNA inserts
corresponding to almost the entire coding sequence (amino
acids 28–335; amino acids 49–335) of Jab1 cDNA. The identi-
ﬁcation of the two independent clones encoding overlapping
regions of Jab1 provides strong conﬁrmation of the speciﬁcity
of the interaction between NRBP and Jab1 in our yeast two-
hybrid assay.
Ectopic expression and coimmunoprecipitation assays were
performed to further examine whether NRBP interacts with
Jab1 in vivo. First, we cotransfected an HA-Jab1 with either
a control vector or a Flag-NRBP in HEK 293T cells. As shown
in Fig. 1A, NRBP associated with Jab1 when co-expressed.
Furthermore, we investigated the in vivo interaction of endog-
enous partners expressed at normal levels. Endogenous NRBP
was precipitated from untreated HEK 293T cell lysates with an
anti-NRBP antiserum. Speciﬁc coimmunoprecipitation of Jab1
was detected by Western blot analysis with an anti-Jab1 anti-
body when the anti-NRBP serum, but not the control serum,
was used for immunoprecipitation (Fig. 1B). Taken together,
our data demonstrate a novel and speciﬁc interaction between
NRBP and Jab1 in mammalian cells.3.2. The N-terminal and the C-terminal regions of NRBP are
both necessary for its binding to Jab1
To further characterize the NRBP-binding domain involved
in the interaction with Jab1, we generated a number of deletion
mutants of NRBP including NRBP (71–535), NRBP (40–535),
NRBP (20–535), NRBP (1–406), NRBP (1–455), and NRBP
(1–485), and examined their abilities to bind to Jab1. As shown
in Fig. 2, full-length NRBP, NRBP (20–535), and NRBP (40–
535) bound to Jab1, whereas NRBP (71–535) failed to bind to
Jab1, suggesting that the region between amino acid 40 and 71
Fig. 1. NRBP interacts with JAB1 in vivo. (A). NRBP associates with
Jab1 in mammalian 293T cells. HEK 293T cells were cotransfected
with pHA-Jab1 and either pEF-Flag-NRBP or pEF-Flag control
vector. Cell lysates were immunoprecipitated with anti-Flag (M2)
antibody followed by immunoblotting with the corresponding anti-
bodies. TCL: total cell lysates. (B). Endogenous NRBP was immuno-
precipitated from HEK 293T cell lysates with the anti-NRBP
antiserum and Jab1 was detected by immunoblotting with the anti-
Jab1 antibody. Precipitation with the preimmune serum served as a
control. The blot was also probed with the anti-NRBP antiserum
(lower panel). Expression level of endogenous Jab1 in the total cell
lysates (TCL) was determined by Western blotting with the anti-Jab1
antibody.
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deletion mutant, NRBP (1–406) failed to interact with Jab1,
indicating that regions in the C terminus of NRBP are also re-
quired for the interaction. Further deletion analysis showed
that the very C-terminal region (residues between 406 and
455) was important in mediating the interaction, since NRBP
(1–455) was capable of binding to Jab1. These data demon-Fig. 2. Mapping the Jab1-interacting regions in NRBP. HEK 293T cells were
Flag vector; lane 2, pEF-Flag-NRBP; lane 3, pEF-Flag-NRBP (20–535); lane
6, pEF-Flag-NRBP (1–485); lane 7, pEF-Flag-NRBP (1–455); and lane 8, pE
Flag antibody followed by immunoblotting with the corresponding antib
determined by Western blotting with an anti-HA antibody.strate that both the N- and the C-terminal regions of NRBP
are involved in the Jab1 association.
3.3. Regulation of AP-1 activity by the interaction of NRBP
with Jab1
The transcriptional coactivator function of Jab1 was initially
characterized by its potent activation of AP-1 transcriptional
activity [10]. Transient transfection assays in 293T cells have re-
vealed that overexpression of NRBP had a moderate inhibitory
eﬀect on basal or c-Jun induced AP-1 activity (Fig. 3A). We
therefore examined whether NRBP, through its binding to
Jab1, might modulate the Jab1-mediated AP-1 activation in
mammalian cells. 293T cells were transfected with an AP-1-dri-
ven luciferase reporter gene in the presence of either a control
vector, c-Jun, or c-Jun together with Jab1. Overexpression of
c-Jun increased the AP-1 activity, which was further potenti-
ated by the coexpression of Jab1 (Fig. 3B). NRBP exhibited a
marked inhibitory eﬀect on the c-Jun and Jab1-mediated AP-
1 activation in a dose-dependent manner. It has been well doc-
umented that AP-1 activation is a critical event in the activation
and proliferation of many cell types including ﬁbroblast and T
cells. Moreover, a recent report has implicated Jab1-mediated
AP-1 induction in proper T cell activation [17]. Consistently,
we also observed a similar inhibitory eﬀect of NRBP on the
Jab1-induced AP-1 activation in Jurkat TAg cells in a dose-
dependent manner (data not shown).
Interaction of Jab1 with c-Jun has been shown to increase
phosphorylation of c-Jun, leading to the activation of AP-1
promoter activity [16]. To determine whether NRBP regulated
the Jab1 function by aﬀecting the level of phosphorylation of
c-Jun, we then examined the levels of c-Jun and phosphory-
lated c-Jun in 293T cells in a similar cotransfection experiment
as described in Fig. 3A. Consistent with previous ﬁndings,
Jab1 induced c-Jun phosphorylation, and more importantly,
NRBP inhibited this potentiation by Jab1 (Fig. 3C), These
data suggest that NRBP not only physically interacts with
Jab1 but also negatively modulates the Jab1-induced AP-1
transcription activity, likely through interfering Jab1-mediated
c-Jun phosphorylation. Our data thus provide a novel insight
into mechanism of action by which NRBP participates in cel-
lular signaling pathways.cotransfected with pHA-Jab1 and the following plasmids: lane 1, pEF-
4, pEF-Flag-NRBP (40–535); lane 5, pEF-Flag-NRBP (71–535); lane
F-Flag-NRBP (1–406). Cell lysates were immunoprecipitated with anti-
odies. Expressions of HA-Jab1 in the total cell lysates (TCL) were
Fig. 3. Regulation of AP-1 activity by the interaction between NRBP and Jab1. (A) NRBP alone can interfere with basal or c-Jun induced AP-1
activity in HEK 293T cells. HEK 293T cells were transiently transfected with diﬀerent amounts of pEF-Flag-NRBP (0.2, 0.4, and 0.8 lg), AP-1
luciferase reporter plasmid, and pEF-Flag-c-Jun or not. The total DNA concentration in each transfection was kept constant by addition with the
empty vector. (B) NRBP inhibits the c-Jun and Jab1-mediated activation of AP-1 reporter activity in HEK 293T cells. HEK 293T cells were
transiently transfected with pEF-Flag-c-Jun, pHA-Jab1, diﬀerent amounts of pEF-Flag-NRBP (0.2, 0.4, and 0.8 lg), and the AP-1 luciferase reporter
plasmid. The total DNA concentration in each transfection was kept constant by addition with the empty vector. (C) NRBP inhibits Jab1-mediated
c-Jun phosphorylation. HEK 293T cells were cotransfected with the indicated cDNAs (designated as in (A)). The cell lysates were resolved on SDS-
PAGE and analyzed by immunoblotting. The status of c-Jun phosphorylation was probed with an anti-phospho-c-Jun (Ser-63) antibody. The total
amount of c-Jun, NRBP and JAB1 was probed with an anti-Flag or an anti-HA antibody, respectively. b-actin immunoblots served as a control.
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NFjB
To further investigate the speciﬁcity and physiological rele-
vance of the negative regulation by NRBP, we examined the
eﬀects of overexpression of NRBP on stimuli-induced gene
transcription in ﬁbroblasts and in T cells. It is well known that
many growth factors and pharmacological agents such as
PMA activate AP-1 activity. We found that overexpression
of NRBP also potently inhibited PMA-induced AP-1 activa-
tion in 293T (Fig. 4A) and Jurkat TAg cells (data not shown).
It is also known that engagement of T cell antigen receptor
(TCR) leads to AP-1 activation in T cells, a critical pre-requi-
site for T cell activation, cytokine secretion and proliferation.
We showed that NRBP inhibited anti-TCR induced AP-1 acti-
vation in Jurkat TAg cells (Fig. 4B). More importantly, the
inhibitory eﬀect on AP-1 activation by NRBP appeared to
be speciﬁc, since overexpression of NRBP completely failed
to interfere with NFjB activation induced by PMA or a natu-
ral agonist TNF in 293T cells (Fig. 4C and D). Taken together,
these results demonstrate that NRBP negatively regulates AP-1 activation in a speciﬁc and physiological manner, likely
through its interaction with Jab1.4. Discussion
NRBP is an ubiquitously expressed multi-domain adapter
protein whose function so far remains largely elusive. Since
its putative kinase domain lacks 7 of the 15 highly conserved
amino acid residues in its catalytic site, it is unlikely to be pos-
sess enzymatic activity as a conventional kinase [18,20]. Other
structural motifs in NRBP are two putative LXXLL nuclear
receptor binding sequences. However, there is not yet any
physical or functional evidence indicating that NRBP can bind
to nuclear receptors. Interestingly, NRBP contains a bipartite
nuclear localization sequence (NLS) and a nuclear export se-
quence (NES). Confocal microscopy and biochemical analyses
revealed that NRBP was present in both the cytoplasm and nu-
cleus, suggesting that it may shuttle between the compartments
[22], and therefore it may regulate subcellular localization and
Fig. 4. NRBP inhibits stimulus-enhanced AP-1 activity. (A) NRBP inhibits PMA-induced activation of AP-1 in HEK 293T cells. Cells were
transiently transfected with either pEF-Flag vector or pEF-Flag-NRBP, together with an AP-1 luciferase reporter plasmid. Cells were either
untreated or treated with 40 ng/ml of PMA for 8–12 h. (B) NRBP inhibits anti-TCR enhanced activation of AP-1 reporter activity in Jurkat TAg
cells. Cells were transiently transfected with either pEF-Flag vector, pEF-Flag-NRBP, together with an AP-1 luciferase reporter plasmid. Cells were
either untreated or treated with 1 lg/ml anti-TCR for 8 h. (C, D) NRBP has no eﬀect on the stimulus-enhanced NFjB activity. HEK 293T cells were
transiently transfected with either pEF-Flag vector, pEF-Flag-NRBP, together with an NFjB luciferase reporter plasmid. Cells were either untreated
or treated with 25 ng/ml PMA (C) or 10 ng/ml TNF-a (D) for 8–12 h.
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ways.
In an attempt to explore potential function of NRBP in cel-
lular signaling pathways, we searched for novel NRBP-interact-
ing proteins using a yeast two-hybrid strategy. We identiﬁed
Jab1, a key regulator for cell growth and gene transcription,
binds to NRBP in vivo, and is negatively regulated by NRBP.
Jab1 is a critical component of CNS and by far the most studied
subunit [13]. CSN is a conserved protein complex which has
now been found to participate in diverse cellular and develop-
mental processes in various eukaryotic organisms. The CSN-
associated protein kinase activity was initially described by
Seeger et al. for the CSN complex puriﬁed from red blood cells
[11]. In addition, the CSN preparation was found to phosphor-
ylate c-Jun (Ser63 and Ser73), IjBa, and the NFjB precursor,
p105, as well as tumor suppressor p53 (Ser149, Thr 150, and
Thr 155) in vitro [2,11]. Jab1 can enhance the c-Jun phosphor-
ylation level through a CSN-associated kinase and stabilize the
binding of c-Jun to AP-1 sites [10]. Several reports have also
implicated that an interaction between Jab1 and c-Jun contrib-
utes to Jab1’s potentiation on AP-1 controlled transcription
processes [16,17,23–25]. Jab1 is proposed to serve as a substrate
docking site, and c-Jun binds via JAB1 to the CSN complex,
leading to the phosphorylation of the amino-terminal c-Jun
activation domain. Our data indicated that NRBP negatively
regulates the level of phosphorylation of c-Jun enhanced byJab1 or PMA, and subsequently down-regulates AP-1 activity
induced by Jab1 or PMA. The inhibitory eﬀect of NRBP on
AP-1 activation likely was mediated through its interaction
with Jab1, rather than aﬀecting the upstream activators such
as JNK, since overexpression of NRBP failed to interfere with
phosphorylation of JNK [20]. It is also noteworthy that Jab1
has been implicated in inﬂuencing other transcription factors
including NFjB through a diﬀerent mechanism [26]. Indeed,
our data demonstrated that NRBP speciﬁcally inhibited
AP-1, but not the NFjB activation induced by various stimuli,
suggesting that NRBP may primarily regulate Jab1-mediated
signaling events leading to AP-1 induction.
Our deletion analyses revealed that both the N-terminus and
the C-terminus of NRBP were required for its interaction with
Jab1 in mammalian cells. Intriguingly, we found that the N-
terminal region encompassing the ﬁrst 99 residues was suﬃ-
cient to interact with Jab1 in yeast (data not shown). It has
been reported that the murine homolog of NRBP, Madm,
interacts with the oncogene MLF1 through a region between
residues 406 and 479 within Madm [19]. Since NRBP (1–455)
was still capable of interacting with Jab1, it is unlikely that
NRBP requires a binding partner like human MLF1 to facili-
tate its association with Jab1 [19]. We therefore hypothesize
that the C-terminal NRBP may provide proper cellular
localization or folding of the protein that allows its interaction
with Jab1 in mammalian cells.
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for cellular functions induced by a variety of stimuli, including
T cell antigen receptor engagement. We found that overexpres-
sion of NRBP in T cells potently inhibited TCR-induced acti-
vation of nuclear factor of activating T cells (NFAT) (data not
shown), in which AP-1 is an integral component. In addition,
we showed that NRBP exerted its function more downstream
of TCR stimulation, likely through Jab1, since other MAPK-
mediated signaling events such as CD69 up-regulation was not
aﬀected by overexpression of NRBP (data not shown). Our
data thus suggest that Jab1 may be an important player in
TCR-induced signaling pathways leading to gene activation.
In fact, a recent report has implicated Jab1’s involvement in
integrin LFA-1-mediated T cell activation [17]. It will be inter-
esting to determine whether NRBP and/or Jab1 serve as a gen-
eral modulator in T cell activation.
Abnormal AP-1 activation can also contribute to oncogene-
sis by aﬀecting transcription of important regulators involved
in cell proliferation, diﬀerentiation, apoptosis, and tumor inva-
sion [27,28]. In addition, Jab1 has recently been strongly asso-
ciated with aggressiveness or inferior overall survival in
various malignancies including pituitary tumors, epithelial
ovarian and breast cancer [29], and some types of lymphoma
[30–33]. Therefore, our discovery of the physical and func-
tional interaction between NRBP and Jab1 not only raises a
possibility of NRBP’s involvement in oncogenesis, but also
provides additional insights into modulation of Jab1 and
AP-1-mediated tumor pathogenesis.
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